D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$408M |
| 2 |
Medtronic
MDT
|
+$271M |
| 3 |
NXP Semiconductors
NXPI
|
+$270M |
| 4 |
Gilead Sciences
GILD
|
+$253M |
| 5 |
Hewlett Packard
HPE
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$424M |
| 2 |
CVS Health
CVS
|
+$391M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$323M |
| 4 |
Wells Fargo
WFC
|
+$280M |
| 5 |
VMW
VMware, Inc
VMW
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.54% |
| 2 | Healthcare | 10.14% |
| 3 | Financials | 8.94% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Industrials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UAM
3276
DELISTED
Universal American Corp
UAM
| $157K | ﹤0.01% |
15,751
+187
| +1% | +$1.64K |
|
3277
CALL
Brookdale Senior Living
BKD
$3.62B
| $156K | ﹤0.01% |
12,600
| – | – |
|
3278
ICL Group
ICL
$6.81B
| $155K | ﹤0.01% |
37,738
-46,988
| -55% | -$181K |
|
|
BCIC
3279
BCP Investment Corp
BCIC
$86.9M
| $154K | ﹤0.01% |
3,867
-277
| -7% | -$11.5K |
|
|
NAVB
3280
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $154K | ﹤0.01% |
12,220
-8,391
| -41% | -$133K |
|
|
JKS
3281
CALL
JinkoSolar
JKS
$775M
| $152K | ﹤0.01% |
10,000
| – | – |
|
|
MXPT
3282
DELISTED
MaxPoint Interactive, Inc.
MXPT
| $152K | ﹤0.01% |
25,388
-3,115
| -11% | -$25.7K |
|
3283
Akebia Therapeutics
AKBA
$327M
| $151K | ﹤0.01% |
14,477
-8,882
| -38% | -$76.5K |
|
3284
Ocular Therapeutix
OCUL
$1.86B
| $150K | ﹤0.01% |
17,953
+2,806
| +19% | +$21.8K |
|
|
P
3285
PUT
DELISTED
Pandora Media Inc
P
| $150K | ﹤0.01% |
+11,500
| New | +$143K |
|
|
SPLS
3286
DELISTED
Staples Inc
SPLS
| $149K | ﹤0.01% |
16,442
-65,380
| -80% | -$570K |
|
|
CVO
3287
DELISTED
Cenevo, Inc.
CVO
| $147K | ﹤0.01% |
21,000
-2,000
| -9% | -$14.3K |
|
|
CFMS
3288
DELISTED
Conformis, Inc. Common Stock
CFMS
| $144K | ﹤0.01% |
+709
| New | +$157K |
|
|
ADXS
3289
CALL
DELISTED
Advaxis Inc
ADXS
| $143K | ﹤0.01% |
1,333
| – | – |
|
3290
Vipshop
VIPS
$6.84B
| $142K | ﹤0.01% |
12,873
-12,927
| -50% | -$167K |
|
3291
Workiva
WK
$2.94B
| $142K | ﹤0.01% |
+10,417
| New | +$160K |
|
3292
Vale
VALE
$62.9B
| $141K | ﹤0.01% |
18,502
-65,097
| -78% | -$477K |
|
|
RGLS
3293
DELISTED
Regulus Therapeutics
RGLS
| $139K | ﹤0.01% |
516
+42
| +9% | +$13.7K |
|
|
ARNA
3294
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $138K | ﹤0.01% |
9,742
+7,722
| +382% | +$120K |
|
|
SSRI
3295
PUT
DELISTED
Silver Standard Resources
SSRI
| $137K | ﹤0.01% |
15,400
+5,400
| +54% | +$54.6K |
|
|
CETV
3296
DELISTED
Central European Media Enterprises Ltd
CETV
| $136K | ﹤0.01% |
53,244
+879
| +2% | +$2.21K |
|
3297
Geron
GERN
$911M
| $134K | ﹤0.01% |
64,499
-1,608
| -2% | -$3.39K |
|
3298
Stagwell
STGW
$1.84B
| $134K | ﹤0.01% |
20,400
-45,118
| -69% | -$334K |
|
|
SRRA
3299
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $134K | ﹤0.01% |
2,248
+1,406
| +167% | +$87.7K |
|
3300
Theriva Biologics
TOVX
$10.2M
| $133K | ﹤0.01% |
+20
| New | +$205K |
|
Similar funds
D.E. Shaw & Co's Q4 2016 Portfolio in Review
As of Q4 2016, D.E. Shaw & Co held 3,804 positions worth $58.9B, up 3.9% from $56.7B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
D.E. Shaw & Co's Q4 2016 filing shows 462 new, 1,382 increased, 1,255 reduced and 397 closed positions. Its largest new stake was Deere & Co: 1,429,259 shares worth $147M. The largest sale was Amazon, an estimated $424M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2016 buy was Deere & Co: 1,429,259 shares worth $147M.
- D.E. Shaw & Co added most to Netflix in Q4 2016, an estimated $408M increase.
- D.E. Shaw & Co's biggest Q4 2016 reduction was Amazon, cutting an estimated $424M.
- D.E. Shaw & Co fully exited LinkedIn Corporation in Q4 2016, selling an estimated $323M.
- D.E. Shaw & Co's ten largest holdings make up 8.8% of its $58.9B portfolio in Q4 2016.
- D.E. Shaw & Co opened 462 new positions and closed 397 in Q4 2016.
- D.E. Shaw & Co's portfolio value rose 3.9% quarter-over-quarter to $58.9B.
Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.